Bax homodimerization is not required for Bax to accelerate chemotherapy-induced cell death

被引:39
作者
Simonian, PL
Grillot, DAM
Andrews, DW
Leber, B
Nunez, G
机构
[1] UNIV MICHIGAN, SCH MED, DEPT PATHOL, ANN ARBOR, MI 48109 USA
[2] UNIV MICHIGAN, SCH MED, CTR COMPREHENS CANC, ANN ARBOR, MI 48109 USA
[3] MCMASTER UNIV, DEPT BIOCHEM, HAMILTON, ON L8N 3Z5, CANADA
[4] MCMASTER UNIV, DEPT MED & BIOCHEM, HAMILTON, ON L8N 3Z5, CANADA
关键词
D O I
10.1074/jbc.271.50.32073
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Bax, a member of the Bcl-2 family of proteins, has been shown to accelerate apoptosis induced by growth factor withdrawal, gamma-irradiation, and the chemotherapeutic agent, etoposide, The mechanism by which Bax promotes apoptosis is poorly understood, Bax forms homodimers which have been suggested to act as accelerators or inducers of cell death, However, the requirement for homodimerization of Bax to promote cell death remains unclear. We performed site-directed mutagenesis of the BH1, BH2, and BH3 in Bax to determine the regions of Bax required for homodimerization and to define the role of fax homodimers in cell death induced by chemotherapy drugs, Bax proteins expressing alanine substitutions of the highly conserved amino acids glycine 108 (G108) in BH1, tryptophan 158 (W158) in BH2, and glycine 67 and aspartic acid 68 (GD67-68) in BH3 as well as deletion of the most conserved amino acids in BH1 (Delta 102-112) and BH2 (Delta 151-159) and deletion of BH3 (Delta 63-71) maintained their ability to accelerate chemotherapy-induced cell death, Immunoprecipitation studies revealed that Bax with deletions in BH1 and BH2 still associated with wild-type Bax while deletion of BH3 disrupted Bax homodimerization. These results demonstrate that Bax does not require the conserved regions of homology, BH1, BH2, or BH3, to accelerate chemotherapy-induced cell death, Furthermore, our results established BH3 as a region required for Bax homodimerization in mammalian cells and demonstrate that monomeric forms of Bax are active in accelerating cell death induced by chemotherapy agents.
引用
收藏
页码:32073 / 32077
页数:5
相关论文
共 30 条
[1]  
Ausubel F.M., 1996, CURRENT PROTOCOLS MO
[2]  
BOYD JM, 1995, ONCOGENE, V11, P1921
[3]   T cells from bax alpha transgenic mice show accelerated apoptosis in response to stimuli but do not show restored DNA damage-induced cell death in the absence of p53 [J].
Brady, HJM ;
Salomons, GS ;
Bobeldijk, RC ;
Berns, AJM .
EMBO JOURNAL, 1996, 15 (06) :1221-1230
[4]   Bax-independent inhibition of apoptosis by Bcl-x(L) [J].
Cheng, EHY ;
Levine, B ;
Boise, LH ;
Thompson, CB ;
Hardwick, JM .
NATURE, 1996, 379 (6565) :554-556
[5]   A CONSERVED DOMAIN IN BAK, DISTINCT FROM BH1 AND BH2, MEDIATES CELL-DEATH AND PROTEIN-BINDING FUNCTIONS [J].
CHITTENDEN, T ;
FLEMINGTON, C ;
HOUGHTON, AB ;
EBB, RG ;
GALLO, GJ ;
ELANGOVAN, B ;
CHINNADURAI, G ;
LUTZ, RJ .
EMBO JOURNAL, 1995, 14 (22) :5589-5596
[6]  
EASTMAN A, 1990, CANCER CELL-MON REV, V2, P275
[7]   APOPTOSIS IN CANCER-THERAPY - CROSSING THE THRESHOLD [J].
FISHER, DE .
CELL, 1994, 78 (04) :539-542
[8]   A peptide sequence from Bax that converts Bcl-2 into an activator of apoptosis [J].
Hunter, JJ ;
Parslow, TG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (15) :8521-8524
[9]  
INNIS MA, 1990, PCR PROTOCOLS GUIDE, P177
[10]   BAX-DEFICIENT MICE WITH LYMPHOID HYPERPLASIA AND MALE GERM-CELL DEATH [J].
KNUDSON, CM ;
TUNG, KSK ;
TOURTELLOTTE, WG ;
BROWN, GAJ ;
KORSMEYER, SJ .
SCIENCE, 1995, 270 (5233) :96-99